BHC Bausch Health Companies Inc. Common Stock
NYSE · Pharmaceuticals · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Jul 30, 2026
$5.80
· of 52w range
· above low
· to high
$4.3352w low
$8.0052w high
Market Cap (MRQ)
$2.17B
P/E (TTM)
-2.0
EPS (TTM)
$-2.96
Revenue (TTM)
$10.85B
your badges
52W Range
$4–$8
Analyst Rating
HOLD
Price Target
$8
P/E
-2.0
ROE
86.6%
Net Profit Margin
-10.1%
Your badge strip is empty — pin a metric anywhere on this page.
BHC Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$5.80
Market Cap (MRQ)
$2.17B
P/E (TTM)
-2.0
EPS (TTM)
$-2.96
Revenue (TTM)
$10.85B
ROE (TTM)
86.6%
Debt/Equity (MRQ)
-11.7
52W Range
$4–$8
BHC Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Oct. 16, 2000 | 2-for-1 | Forward |
| Jan. 20, 2000 | 2-for-1 | Forward |
| Jan. 17, 1996 | 3-for-1 | Forward |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$10.27B2016-12-31 → 2025-12-31
EPS$0.422016-12-31 → 2025-12-31
Free Cash Flow$1.00B2016-12-31 → 2025-12-31
Net margin-10.1%2016-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | BHC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -2.05Y avg ≈-14.2 | ≈-14.2 | · | · | |
| P/S (TTM) | 0.25Y avg ≈0.5 | ≈0.5 | · | · | |
| P/B (MRQ) | -1.25Y avg ≈-21.3 | ≈-21.3 | · | · | |
| EV / EBITDA | 11.95Y avg ≈34.6 | ≈34.6 | · | · | |
| Price / FCF (TTM) | 1.55Y avg ≈2.9 | ≈2.9 | · | · | |
| Price / Cash Flow (TTM) | 1.25Y avg ≈2.1 | ≈2.1 | · | · | |
| EV / Revenue | 2.15Y avg ≈2.8 | ≈2.8 | · | · | |
| EV / FCF | 21.65Y avg ≈14.9 | ≈14.9 | · | · | |
| Price / Tangible Book (MRQ) | -0.4 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | BHC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin (TTM) | 8.1%5Y avg ≈11.1% | ≈11.1% | · | · | |
| EBITDA Margin | 17.7%5Y avg ≈11.1% | ≈11.1% | · | · | |
| Pretax Margin (TTM) | -6.7%5Y avg ≈-2.6% | ≈-2.6% | · | · | |
| Net Profit Margin (TTM) | -10.1%5Y avg ≈-3.9% | ≈-3.9% | · | · | |
| ROA (TTM) | -4.2%5Y avg ≈-1.2% | ≈-1.2% | · | · | |
| ROE (TTM) | 86.6%5Y avg ≈-65.9% | ≈-65.9% | · | · | |
| ROIC | 2.9%5Y avg ≈2.5% | ≈2.5% | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | BHC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (MRQ) | -11.75Y avg ≈-64.0 | ≈-64.0 | · | · | |
| Current Ratio (MRQ) | 1.45Y avg ≈1.2 | ≈1.2 | · | · | |
| Quick Ratio | 0.95Y avg ≈0.6 | ≈0.6 | · | · | |
| Long-Term Debt / Equity (MRQ) | -11.25Y avg ≈-63.3 | ≈-63.3 | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | BHC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 6.7%5Y avg ≈5.2% | ≈5.2% | · | · | |
| Revenue CAGR 3Y | 8.1%5Y avg ≈5.2% | ≈5.2% | · | · | |
| Revenue CAGR 5Y | 5.0% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | BHC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.45Y avg ≈0.3 | ≈0.3 | · | · | |
| Receivables Turnover | 4.65Y avg ≈4.7 | ≈4.7 | · | · | |
| Revenue / Employee | ≈$505.7K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Dividends Yield, payout ratio, dividend history, 5Y CAGR
Annualized Payout≈$4.00
| Ex-date | Amount | Currency | Yield |
|---|---|---|---|
| Nov 10, 2010 | $1.00 | USD | ≈5.0% |
| Aug 30, 2010 | $0.10 | USD | ≈1.6% |
| May 28, 2010 | $0.10 | USD | ≈2.4% |
| Mar 4, 2010 | $0.09 | USD | ≈4.8% |
| Nov 30, 2009 | $0.09 | USD | ≈7.1% |
| Aug 28, 2009 | $0.09 | USD | ≈7.3% |
| May 13, 2009 | $0.09 | USD | ≈11.2% |
| Mar 6, 2009 | $0.38 | USD | ≈13.9% |
| Dec 19, 2008 | $0.38 | USD | ≈16.6% |
| Aug 21, 2008 | $0.38 | USD | ≈14.9% |
| May 20, 2008 | $0.38 | USD | ≈12.3% |
| Mar 25, 2008 | $0.38 | USD | ≈13.8% |
| Nov 16, 2007 | $0.38 | USD | ≈12.7% |
| Aug 16, 2007 | $0.38 | USD | ≈10.5% |
| May 18, 2007 | $0.38 | USD | ≈6.6% |
| Mar 22, 2007 | $0.38 | USD | ≈5.8% |
| Jan 8, 2007 | $0.50 | USD | ≈4.9% |
| Nov 20, 2006 | $0.13 | USD | ≈5.8% |
| Aug 16, 2006 | $0.13 | USD | ≈5.5% |
| May 19, 2006 | $0.13 | USD | ≈3.0% |
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-1.8%
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | $1.26 | $1.05 | 20.3% | |
| March 31, 2026 | $0.78 | $0.69 | 12.3% | |
| Dec. 31, 2025 | $1.10 | $1.28 | -13.9% | |
| Sept. 30, 2025 | $1.16 | $1.13 | 2.6% | |
| June 30, 2025 | $0.91 | $0.98 | -7.1% | |
| March 31, 2025 | $0.60 | $0.80 | -25.1% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.27B | $9.62B | $8.76B | $8.12B | $8.43B | $8.03B | $8.60B | $8.38B | $8.72B | $9.67B | $10.45B | $8.21B | |
| Cost of Revenue | · | · | · | · | · | · | · | · | $2.51B | $2.57B | $2.53B | $2.18B | |
| SG&A Expense | $3.44B | $3.30B | $2.92B | $2.62B | $2.62B | $2.37B | $2.55B | $2.47B | $2.58B | $2.81B | $2.70B | $2.03B | |
| Operating Expenses | $8.45B | $8.08B | $7.79B | $7.67B | $7.98B | $7.35B | $8.80B | $10.76B | $8.62B | $10.24B | $8.92B | $6.21B | |
| Operating Income | $1.81B | $1.55B | $963M | $454M | $450M | $676M | $-203M | $-2.38B | $102M | $-566M | $1.53B | $2.00B | |
| Interest Income | $48M | $33M | $26M | $14M | $7M | $13M | $12M | $11M | $12M | $8M | $4M | $5M | |
| Other Non-op | $-142M | $-247M | $-28M | $-35M | $-373M | $-502M | $-1.43B | $20M | $348M | $-73M | $-295M | $263M | |
| Pretax Income | $367M | $167M | $-390M | $-129M | $-1.02B | $-934M | $-1.84B | $-4.15B | $-1.74B | $-2.44B | $-155M | $1.05B | |
| Income Tax | $247M | $239M | $221M | $83M | $-87M | $-375M | $-54M | $-10M | $-4.14B | $-27M | $133M | $174M | |
| Net Income | $157M | $-46M | $-592M | $-225M | $-948M | $-560M | $-1.79B | $-4.14B | $2.40B | $-2.41B | $-288M | $880M | |
| EPS (Basic) | $0.42 | $-0.13 | $-1.62 | $-0.62 | $-2.64 | $-1.58 | $-5.08 | $-11.81 | $6.86 | $-6.94 | $-0.85 | $2.63 | |
| EPS (Diluted) | $0.42 | $-0.13 | $-1.62 | $-0.62 | $-2.64 | $-1.58 | $-5.08 | $-11.81 | $6.83 | $-6.94 | $-0.85 | $2.58 | |
| Shares (Basic) | 370,900,000 | 368,000,000 | 364,900,000 | 362,000,000 | 358,900,000 | 355,000,000 | 352,100,000 | 351,300,000 | 350,200,000 | 347,300,000 | 342,700,000 | 335,400,000 | |
| Shares (Diluted) | 375,000,000 | 368,000,000 | 364,900,000 | 362,000,000 | 358,900,000 | 355,000,000 | 352,100,000 | 351,300,000 | 351,800,000 | 347,300,000 | 342,700,000 | 341,500,000 | |
| EBITDA | $1.81B | $1.55B | $963M | $454M | $450M | $676M | $-203M | $-2.38B | $102M | $-566M | $1.53B | $2.04B |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.31B | $1.18B | $947M | $564M | $582M | $605M | $3.24B | $721M | $720M | $542M | $597M | $323M | |
| Receivables | $2.35B | $2.14B | $2.00B | $1.79B | $1.77B | $1.58B | $1.84B | $1.86B | $2.13B | $2.52B | $2.69B | $2.08B | |
| Inventory | $1.63B | $1.59B | $1.54B | $1.09B | $993M | $1.09B | $1.11B | $934M | $1.05B | $1.06B | $1.26B | $889M | |
| Prepaid Expense | $852M | $838M | $1.09B | $776M | $720M | $855M | $779M | $689M | $771M | $696M | $963M | $651M | |
| Current Assets | $6.16B | $5.77B | $5.60B | $4.25B | $5.61B | $5.34B | $6.97B | $4.21B | $4.75B | $5.08B | $5.51B | $4.13B | |
| PP&E (Net) | $2.07B | $1.78B | $1.71B | $1.60B | $1.60B | $1.57B | $1.47B | $1.35B | $1.40B | $1.31B | $1.44B | $1.31B | |
| PP&E (Gross) | $4.50B | $3.92B | $3.79B | $3.52B | $3.42B | $3.35B | $3.11B | $2.88B | $2.83B | $2.51B | $2.63B | $2.29B | |
| Accum. Depreciation | $2.42B | $2.14B | $2.08B | $1.92B | $1.82B | $1.78B | $1.64B | $1.52B | $1.43B | $1.20B | $1.18B | $978M | |
| Goodwill | $11.27B | $11.09B | $11.18B | $11.55B | $12.46B | $13.04B | $13.13B | $13.14B | $15.59B | $15.79B | $18.55B | $9.36B | |
| Intangibles | $4.64B | $5.55B | $6.46B | $5.80B | $6.95B | $8.45B | $10.20B | $12.00B | $15.21B | $18.88B | $23.08B | $11.28B | |
| Other Non-current Assets | $378M | $363M | $307M | $326M | $340M | $664M | $411M | $109M | $111M | $184M | $224M | $167M | |
| Total Assets | $26.37B | $26.52B | $27.35B | $25.69B | $29.20B | $31.20B | $33.86B | $32.49B | $37.50B | $43.53B | $48.97B | $26.30B | |
| Accounts Payable | $600M | $589M | $719M | $521M | $407M | $337M | $503M | $411M | $365M | $324M | $434M | $398M | |
| Accrued Liabilities | $3.34B | $3.49B | $3.13B | $2.99B | $4.79B | $4.58B | $4.51B | $3.20B | $3.69B | $3.23B | $3.86B | $2.16B | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | $6M | $16M | $6M | |
| Current Liabilities | $4.18B | $6.75B | $4.30B | $3.94B | $5.20B | $4.91B | $6.25B | $3.84B | $4.27B | $3.61B | $5.31B | $2.71B | |
| Capital Leases | $167M | $165M | $148M | $184M | $214M | $227M | $240M | · | · | · | · | · | |
| Deferred Tax | $147M | $128M | $163M | $202M | $529M | $528M | $705M | $885M | $1.18B | $5.43B | $5.90B | $2.22B | |
| Other Non-current Liabilities | $793M | $713M | $776M | $741M | $653M | $1.01B | $851M | $581M | $526M | $486M | $185M | $197M | |
| Total Liabilities | $25.99B | $26.84B | $27.43B | $25.43B | $29.24B | $30.59B | $32.73B | $29.68B | $31.55B | $40.27B | $42.94B | $20.90B | |
| Long-term Debt | $20.82B | $21.62B | $22.39B | $20.77B | $22.65B | $23.93B | $25.89B | $24.30B | $25.44B | $29.85B | $31.09B | $15.23B | |
| Total Debt | $20.82B | $21.62B | $22.39B | $20.77B | $22.65B | $23.93B | $25.89B | $24.30B | $25.44B | $29.85B | $31.10B | $15.26B | |
| Common Stock | $10.52B | $10.49B | $10.42B | $10.39B | $10.32B | $10.23B | $10.17B | $10.12B | $10.09B | $10.04B | $9.90B | $8.35B | |
| Retained Earnings | $-9.67B | $-9.82B | $-9.78B | $-9.19B | $-8.96B | $-8.01B | $-7.45B | $-5.66B | $-2.73B | $-5.13B | $-2.75B | $-2.40B | |
| AOCI | $-1.76B | $-2.18B | $-1.88B | $-2.06B | $-1.92B | $-2.13B | $-2.09B | $-2.14B | $-1.90B | $-2.11B | $-1.54B | $-916M | |
| Stockholders' Equity | $-554M | $-1.28B | $-1.02B | $-692M | $-106M | $535M | $1.06B | $2.73B | $5.85B | $3.15B | $5.91B | $5.28B | |
| Liabilities + Equity | $26.37B | $26.52B | $27.35B | $25.69B | $29.20B | $31.20B | $33.86B | $32.49B | $37.50B | $43.53B | $48.97B | $26.30B | |
| Shares Outstanding | 370,531,987 | 367,843,058 | 365,238,917 | 361,898,846 | 359,405,748 | 355,422,347 | 352,562,636 | 349,871,102 | 348,708,567 | 347,821,606 | 342,926,531 | 334,402,964 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.21B | $1.27B | $1.26B | $1.39B | $1.55B | $1.82B | $2.08B | $2.82B | $2.86B | $2.87B | $2.47B | $1.61B | |
| Stock-based Comp | $216M | $150M | $132M | $126M | $128M | $105M | $102M | $87M | $87M | $165M | $140M | $78M | |
| Deferred Tax | $132M | $69M | $6M | $-188M | $-36M | $-599M | $-182M | $-337M | $-4.31B | $-268M | $56M | $23M | |
| Restructuring | · | · | · | · | · | $22M | $31M | $22M | $52M | $132M | $362M | $382M | |
| Operating Cash Flow | $1.40B | $1.60B | $1.03B | $-728M | $1.43B | $1.11B | $1.50B | $1.50B | $2.29B | $2.09B | $2.26B | $2.31B | |
| CapEx | $397M | $337M | $215M | $218M | $269M | $302M | $270M | $157M | $171M | $235M | $235M | $292M | |
| Investing Cash Flow | $-595M | $-454M | $-2.15B | $-303M | $409M | $-261M | $-419M | $-196M | $2.89B | $-125M | $-15.58B | $-100M | |
| Debt Issued | $10.55B | $661M | $3.29B | $6.84B | $2.10B | $3.46B | $5.96B | $8.94B | $9.42B | $1.22B | $17.82B | $1.63B | |
| Net Debt Issued | $-637M | $-799M | $1.58B | $-1.01B | $-1.34B | $-2.19B | $1.55B | $-1.16B | $-4.78B | $-1.22B | $15.76B | $-2.26B | |
| Stock Issued | · | · | · | · | · | · | · | · | $0 | $0 | $1.43B | $0 | |
| Stock Repurchased | · | · | · | · | · | · | · | · | $0 | $0 | $72M | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | $0 | $0 | $1.36B | $0 | |
| Financing Cash Flow | $-742M | $-868M | $1.48B | $-474M | $-1.51B | $-2.29B | $1.44B | $-1.35B | $-4.96B | $-1.96B | $13.62B | $-2.46B | |
| Net Change in Cash | $124M | $239M | $371M | $-1.53B | $303M | $-1.43B | $2.52B | $-74M | $255M | $-55M | $274M | · | |
| Taxes Paid | $163M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.00B | $1.26B | $817M | $-946M | $1.16B | $809M | $1.23B | $1.34B | $2.12B | $1.85B | $1.97B | $2.00B |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 17.7% | 16.1% | 11.0% | 5.6% | 5.3% | 8.4% | -2.4% | -28.4% | 1.2% | -5.9% | 14.6% | 24.7% | |
| Net Margin | 1.5% | -0.48% | -6.8% | -2.8% | -11.2% | -7.0% | -20.7% | -49.5% | 27.6% | -24.9% | -2.8% | 11.0% | |
| Pretax Margin | 3.6% | 1.7% | -4.5% | -1.6% | -12.1% | -11.6% | -21.4% | -49.6% | -20.0% | -25.2% | -1.5% | 13.2% | |
| EBITDA Margin | 17.7% | 16.1% | 11.0% | 5.6% | 5.3% | 8.4% | -2.4% | -28.4% | 1.2% | -5.9% | 14.6% | 24.7% | |
| ROA | 0.59% | -0.17% | -2.2% | -0.82% | -3.1% | -1.7% | -5.4% | -11.8% | 5.9% | -5.2% | -0.76% | 3.4% | |
| ROE | -17.1% | 4.0% | 69.1% | 56.4% | -442.0% | -70.0% | -93.9% | -114.0% | 53.4% | -53.1% | -5.1% | 17.5% | |
| ROIC | 2.9% | -3.3% | 7.1% | 3.7% | 1.8% | 1.7% | -0.73% | -8.8% | -0.45% | -1.7% | 7.6% | 8.3% |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 0.9 | 1.3 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.4 | 1.0 | 1.5 | |
| Quick Ratio | 0.9 | 0.5 | 0.7 | 0.6 | 0.5 | 0.4 | 0.8 | 0.7 | 0.7 | 0.8 | 0.6 | 0.9 | |
| Debt / Equity | -37.6 | -16.9 | -21.9 | -30.0 | -213.7 | 44.7 | 24.4 | 8.9 | 4.4 | 9.5 | 5.3 | 2.9 | |
| LT Debt / Equity | -37.2 | -14.8 | -21.5 | -29.4 | -213.7 | 44.7 | 23.2 | 8.8 | 4.3 | 9.5 | 5.1 | 2.9 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | 0.3 | 0.3 | 0.3 | 0.2 | 0.3 | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 | |
| Inventory Turnover | · | · | · | · | · | · | · | · | 2.4 | 2.2 | 2.4 | 2.4 | |
| Receivables Turnover | 4.6 | 4.7 | 4.6 | 4.6 | 5.0 | 4.7 | 4.6 | 4.2 | 3.8 | 3.7 | 4.4 | 4.4 |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-1.50 | $-3.48 | $-2.80 | $-1.91 | $-0.29 | $1.51 | $3.02 | $7.81 | $16.77 | $9.06 | $17.24 | $15.89 | |
| Revenue / Share | $27.38 | $26.15 | $24.00 | $22.44 | $23.50 | · | $24.43 | $23.85 | $24.80 | $27.85 | $30.48 | $24.20 | |
| Cash Flow / Share | $3.73 | $4.34 | $2.83 | $-2.01 | $3.97 | · | $4.26 | $4.27 | $6.51 | $6.01 | $6.42 | $6.72 | |
| Cash / Share | $3.53 | $3.21 | $2.59 | $1.56 | $1.62 | $1.70 | $9.20 | $2.06 | $2.06 | $1.56 | $1.74 | $0.96 | |
| EPS (TTM) | $0.42 | $-0.13 | $-1.62 | $-0.62 | $-2.64 | $-1.58 | $-5.08 | $-11.81 | $6.83 | $-6.94 | $-0.85 | $2.58 |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 6.7% | 9.9% | 7.8% | -3.7% | 5.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 8.1% | 4.5% | 2.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 5.0% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $10.27B | $9.62B | $8.76B | $8.12B | $8.43B | $8.03B | $8.60B | $8.38B | $8.72B | $9.67B | $10.45B | $8.21B | |
| Net Income TTM | $157M | $-46M | $-592M | $-225M | $-948M | $-560M | $-1.79B | $-4.14B | $2.40B | $-2.41B | $-288M | $880M | |
| Market Cap | $2.58B | $2.96B | $2.93B | $2.27B | $9.92B | $7.39B | $10.55B | $6.46B | $7.25B | $5.05B | $34.86B | $47.86B | |
| Enterprise Value | $22.08B | $23.40B | $24.37B | $22.47B | $32.00B | $30.71B | $33.20B | $30.05B | $31.97B | $34.36B | $65.37B | $62.79B | |
| P/E | 16.5 | -62.0 | -5.0 | -10.1 | -10.5 | -13.2 | -5.9 | -1.6 | 3.0 | -2.1 | -119.6 | 55.5 | |
| P/S | 0.3 | 0.3 | 0.3 | 0.3 | 1.2 | 0.9 | 1.2 | 0.8 | 0.8 | 0.5 | 3.3 | 5.8 | |
| P/B | -4.6 | -2.3 | -2.9 | -3.3 | -93.6 | 13.8 | 9.9 | 2.4 | 1.2 | 1.6 | 5.9 | 9.0 | |
| P / Cash Flow | 1.8 | 1.9 | 2.8 | -3.1 | 7.0 | 6.7 | 7.0 | 4.3 | 3.2 | 2.4 | 15.8 | 20.9 | |
| P / FCF | 2.6 | 2.4 | 3.6 | -2.4 | 8.6 | 9.1 | 8.6 | 4.8 | 3.4 | 2.7 | 17.7 | 23.9 | |
| EV / EBITDA | 12.2 | 15.1 | 25.3 | 49.5 | 71.1 | 45.4 | -163.6 | -12.6 | 313.4 | -60.7 | 42.8 | 30.8 | |
| EV / FCF | 22.0 | 18.6 | 29.8 | -23.8 | 27.7 | 38.0 | 27.0 | 22.4 | 15.1 | 18.6 | 33.3 | 31.3 | |
| EV / Revenue | 2.2 | 2.4 | 2.8 | 2.8 | 3.8 | 3.8 | 3.9 | 3.6 | 3.7 | 3.6 | 6.3 | 7.7 | |
| Earnings Yield | 6.0% | -1.6% | -20.2% | -9.9% | -9.6% | -7.6% | -17.0% | -63.9% | 32.9% | -47.8% | -0.84% | 1.8% |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.85B | $2.52B | $2.80B | $2.68B | $2.53B | $2.26B | $2.56B | $2.51B | $2.40B | $2.15B | $2.41B | $2.24B | $2.17B | $1.94B | $2.19B | $2.05B | |
| SG&A Expense | $907M | $861M | $882M | $795M | $894M | $867M | $820M | $850M | $832M | $794M | $766M | $715M | $711M | $725M | $666M | $661M | |
| Operating Expenses | $2.11B | $3.47B | $2.32B | $2.06B | $2.09B | $1.98B | $2.00B | $2.19B | $2.01B | $1.87B | $2.05B | $2.22B | $1.75B | $1.77B | $2.43B | $1.80B | |
| Operating Income | $740M | $-950M | $474M | $619M | $444M | $276M | $558M | $318M | $389M | $281M | $362M | $14M | $412M | $175M | $-236M | $244M | |
| Interest Income | $11M | $10M | $9M | $15M | $13M | $11M | $9M | $7M | $8M | $9M | $7M | $6M | $7M | $6M | $6M | $3M | |
| Other Non-op | · | · | · | · | · | · | $-2M | $-225M | $-20M | $0 | $-28M | $-60M | $83M | $-23M | $-29M | $-4M | |
| Pretax Income | $348M | $-1.35B | $56M | $218M | $140M | $-47M | $209M | $-21M | $48M | $-69M | $-7M | $-326M | $79M | $-136M | $-357M | $439M | |
| Income Tax | $88M | $77M | $159M | $37M | $12M | $39M | $111M | $71M | $49M | $8M | $40M | $56M | $52M | $73M | $53M | $36M | |
| Net Income | $258M | $-1.42B | $-112M | $179M | $148M | $-58M | $93M | $-85M | $10M | $-64M | $-39M | $-378M | $26M | $-201M | $-410M | $399M | |
| EPS (Basic) | $0.69 | $-3.82 | $-0.30 | $0.48 | $0.40 | $-0.16 | $0.24 | $-0.23 | $0.03 | $-0.17 | $-0.11 | $-1.03 | $0.07 | $-0.55 | $-1.13 | $1.10 | |
| EPS (Diluted) | $0.68 | $-3.82 | $-0.30 | $0.48 | $0.40 | $-0.16 | $0.24 | $-0.23 | $0.03 | $-0.17 | $-0.11 | $-1.03 | $0.07 | $-0.55 | $-1.13 | $1.10 | |
| Shares (Basic) | 375,000,000 | 372,800,000 | · | 371,300,000 | 370,900,000 | 369,600,000 | · | 368,400,000 | 367,900,000 | 366,800,000 | · | 365,400,000 | 364,800,000 | 363,300,000 | · | 362,500,000 | |
| Shares (Diluted) | 378,100,000 | 372,800,000 | · | 375,500,000 | 373,100,000 | 369,600,000 | · | 368,400,000 | 370,200,000 | 366,800,000 | · | 365,400,000 | 367,100,000 | 363,300,000 | · | 363,400,000 | |
| EBITDA | $740M | $-950M | · | $619M | $444M | $276M | · | $318M | $389M | $281M | · | $14M | $412M | $175M | · | $244M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.82B | $1.30B | $1.31B | $1.31B | $1.73B | $1.13B | $1.18B | $719M | $595M | $733M | $947M | $760M | $579M | $518M | $564M | $486M | |
| Receivables | $2.26B | $2.19B | $2.35B | $2.42B | $2.21B | $2.07B | $2.14B | $2.09B | $2.10B | $2.05B | · | $1.95B | $1.74B | $1.69B | · | $1.74B | |
| Inventory | $1.60B | $1.60B | $1.63B | $1.60B | $1.66B | $1.61B | $1.59B | $1.66B | $1.61B | $1.64B | · | $1.27B | $1.24B | $1.22B | · | $1.06B | |
| Prepaid Expense | $819M | $874M | $852M | $894M | $906M | $890M | $838M | $852M | $874M | $957M | · | $1.05B | $890M | $796M | · | $718M | |
| Current Assets | $6.52B | $5.98B | $6.16B | $6.25B | $6.51B | $5.73B | $5.77B | $5.35B | $5.21B | $5.40B | · | $5.05B | $4.46B | $4.24B | · | $4.01B | |
| PP&E (Net) | · | · | $2.07B | $2.03B | $1.99B | $1.88B | $1.78B | $1.79B | $1.74B | $1.71B | · | $1.58B | $1.60B | $1.60B | · | $1.51B | |
| PP&E (Gross) | · | · | $4.50B | · | · | · | $3.92B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $2.42B | · | · | · | $2.14B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $9.79B | $9.81B | $11.27B | $11.29B | $11.30B | $11.15B | $11.09B | $11.17B | $11.13B | $11.16B | $11.18B | $11.19B | $11.63B | $11.58B | $11.55B | $12.04B | |
| Intangibles | $4.18B | $4.40B | $4.64B | $4.83B | $5.05B | $5.30B | $5.55B | $5.65B | $5.90B | $6.18B | · | $6.73B | $5.30B | $5.55B | · | $6.02B | |
| Other Non-current Assets | $358M | $369M | $378M | $382M | $388M | $380M | $363M | $389M | $329M | $312M | · | $328M | $325M | $318M | · | $341M | |
| Total Assets | $24.79B | $24.50B | $26.37B | $26.82B | $27.27B | $26.42B | $26.52B | $26.54B | $26.50B | $26.91B | · | $27.06B | $25.50B | $25.45B | · | $26.30B | |
| Accounts Payable | $593M | $593M | $600M | $616M | $627M | $620M | $589M | $667M | $579M | $642M | · | $569M | $515M | $561M | · | $486M | |
| Accrued Liabilities | $3.07B | $3.04B | $3.34B | $3.60B | $3.47B | $3.35B | $3.49B | $3.39B | $3.34B | $3.23B | · | $3.12B | $3.01B | $2.92B | · | $2.93B | |
| Current Liabilities | $4.54B | $4.53B | $4.18B | $4.79B | $4.97B | $4.26B | $6.75B | $4.51B | $4.37B | $4.41B | · | $4.22B | $3.97B | $3.92B | · | $3.83B | |
| Capital Leases | · | · | $167M | · | · | · | $165M | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $211M | $179M | $147M | $145M | $144M | $134M | $128M | $169M | $170M | $170M | · | $213M | $215M | $205M | · | $422M | |
| Other Non-current Liabilities | $733M | $763M | $793M | $843M | $877M | $761M | $713M | $805M | $745M | $751M | · | $721M | $745M | $746M | · | $619M | |
| Total Liabilities | $25.60B | $25.58B | $25.99B | $26.47B | $27.12B | $26.66B | $26.84B | $26.78B | $26.72B | $27.09B | · | $27.30B | $25.23B | $25.30B | · | $25.86B | |
| Long-term Debt | $20.74B | $20.76B | $20.82B | $21.04B | $21.74B | $21.51B | $21.62B | $21.51B | $21.66B | $22.07B | · | $22.43B | $20.55B | $20.65B | · | $21.21B | |
| Total Debt | $20.74B | $20.76B | · | $21.04B | $21.74B | $21.51B | · | $21.51B | $21.66B | $22.07B | · | $22.43B | $20.55B | $20.65B | · | $21.21B | |
| Common Stock | $10.54B | $10.54B | $10.52B | $10.52B | $10.51B | $10.51B | $10.49B | $10.49B | $10.48B | $10.48B | · | $10.42B | $10.41B | $10.40B | · | $10.39B | |
| Retained Earnings | $-10.83B | $-11.09B | $-9.67B | $-9.55B | $-9.73B | $-9.88B | $-9.82B | $-9.92B | $-9.83B | $-9.84B | · | $-9.74B | $-9.36B | $-9.39B | · | $-8.78B | |
| AOCI | $-1.82B | $-1.81B | $-1.76B | $-1.80B | $-1.79B | $-2.03B | $-2.18B | $-1.95B | $-2.01B | $-1.92B | · | $-2.05B | $-1.90B | $-1.99B | · | $-2.27B | |
| Stockholders' Equity | $-1.77B | $-2.06B | $-554M | $-565M | $-764M | $-1.18B | $-1.28B | $-1.17B | $-1.18B | $-1.11B | · | $-1.18B | $-663M | $-800M | · | $-525M | |
| Liabilities + Equity | $24.79B | $24.50B | $26.37B | $26.82B | $27.27B | $26.42B | $26.52B | $26.54B | $26.50B | $26.91B | · | $27.06B | $25.50B | $25.45B | · | $26.30B | |
| Shares Outstanding | 373,901,440 | 373,464,760 | 370,531,987 | 370,473,221 | 369,749,489 | 369,539,455 | 367,843,058 | 367,695,267 | 366,985,967 | 366,674,264 | · | 365,043,317 | 364,063,514 | 363,607,062 | · | 361,781,292 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $281M | $295M | $290M | $306M | $307M | $305M | $307M | $322M | $318M | $320M | $329M | $301M | $315M | $319M | $360M | $335M | |
| Stock-based Comp | $54M | $52M | $84M | $43M | $46M | $43M | $43M | $38M | $36M | $33M | $29M | $29M | $33M | $41M | $35M | $33M | |
| Operating Cash Flow | $670M | $230M | $495M | $405M | $289M | $211M | $601M | $405M | $380M | $211M | $390M | $282M | $206M | $154M | $475M | $-1.26B | |
| CapEx | $77M | $109M | $92M | $91M | $99M | $115M | $106M | $71M | $78M | $82M | $98M | $42M | $28M | $47M | $66M | $54M | |
| Investing Cash Flow | $-93M | $-139M | $-282M | $-83M | $-100M | $-130M | $-200M | $-102M | $-79M | $-73M | $-148M | $-1.89B | $-30M | $-78M | $-136M | $-53M | |
| Debt Issued | $84M | $2.80B | $133M | $-1M | $10.37B | $50M | $506M | $0 | $80M | $75M | $146M | $2.69B | $300M | $155M | $355M | $161M | |
| Net Debt Issued | · | $-55M | · | · | · | $-118M | · | · | · | $-315M | · | · | · | $-124M | · | · | |
| Financing Cash Flow | $-49M | $-100M | $-235M | $-719M | $358M | $-146M | $85M | $-189M | $-424M | $-340M | $-79M | $1.82B | $-120M | $-142M | $-276M | $-36M | |
| Net Change in Cash | $526M | $-13M | $-15M | $-403M | $586M | $-44M | $451M | $127M | $-132M | $-207M | $182M | $192M | $57M | $-60M | $94M | $-1.38B | |
| Free Cash Flow | · | $121M | · | · | · | $96M | · | · | · | $129M | · | · | · | $107M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 25.9% | -37.6% | · | 23.1% | 17.5% | 12.2% | · | 12.7% | 16.2% | 13.1% | · | 0.63% | 19.0% | 9.0% | · | 11.9% | |
| Net Margin | 9.0% | -56.4% | · | 6.7% | 5.9% | -2.6% | · | -3.4% | 0.42% | -3.0% | · | -16.9% | 1.2% | -10.3% | · | 19.5% | |
| Pretax Margin | 12.2% | -53.6% | · | 8.1% | 5.5% | -2.1% | · | -0.84% | 2.0% | -3.2% | · | -14.6% | 3.6% | -7.0% | · | 21.5% | |
| EBITDA Margin | 25.9% | -37.6% | · | 23.1% | 17.5% | 12.2% | · | 12.7% | 16.2% | 13.1% | · | 0.63% | 19.0% | 9.0% | · | 11.9% | |
| ROA | 0.99% | -5.6% | · | 0.67% | 0.55% | -0.22% | · | -0.32% | 0.04% | -0.24% | · | -1.4% | 0.10% | -0.74% | · | 1.4% | |
| ROE | -20.4% | 87.8% | · | -20.6% | -15.3% | 5.1% | · | 7.2% | -1.1% | 6.7% | · | 44.3% | -3.8% | 39.6% | · | -109.5% | |
| ROIC | 2.9% | -5.4% | · | 2.5% | 1.9% | 2.5% | · | 6.9% | -0.04% | 1.5% | · | 0.08% | 0.71% | 1.4% | · | 1.1% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.3 | · | 1.3 | 1.3 | 1.3 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | 1.1 | 1.1 | · | 1.0 | |
| Quick Ratio | 0.9 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | |
| Debt / Equity | -11.7 | -10.1 | · | -37.2 | -28.5 | -18.2 | · | -18.3 | -18.4 | -19.8 | · | -19.0 | -31.0 | -25.8 | · | -40.4 | |
| LT Debt / Equity | -11.2 | -9.7 | · | -36.2 | -27.3 | -17.9 | · | -17.9 | -18.0 | -19.3 | · | -18.6 | -30.3 | -25.3 | · | -39.6 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 1.3 | 1.2 | · | 1.2 | 1.2 | 1.1 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | 1.3 | 1.2 | · | 1.2 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-4.74 | $-5.51 | · | $-1.53 | $-2.07 | $-3.20 | · | $-3.19 | $-3.20 | $-3.04 | · | $-3.23 | $-1.82 | $-2.20 | · | $-1.45 | |
| Revenue / Share | $7.54 | $6.77 | · | $7.14 | $6.78 | $6.11 | · | $6.81 | $6.49 | $5.87 | · | $6.12 | $5.90 | $5.35 | · | $5.63 | |
| Cash Flow / Share | · | $0.62 | · | · | · | $0.57 | · | · | · | $0.58 | · | · | · | $0.42 | · | · | |
| Cash / Share | $4.88 | $3.48 | · | $3.53 | $4.67 | $3.07 | · | $1.96 | $1.62 | $2.00 | · | $2.08 | $1.59 | $1.42 | · | $1.34 | |
| EPS (TTM) | $-2.96 | $-3.24 | · | $0.96 | $0.25 | $-0.12 | · | $-0.48 | $-1.28 | $-1.24 | · | $-2.64 | $-0.51 | $-0.98 | · | $0.72 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $10.85B | $10.53B | · | $10.03B | $9.86B | $9.73B | · | $9.47B | $9.20B | $8.97B | · | $8.54B | $8.35B | $8.15B | · | $8.13B | |
| Net Income TTM | $-1.10B | $-1.21B | · | $362M | $98M | $-40M | · | $-178M | $-471M | $-455M | · | $-963M | $-186M | $-357M | · | $254M | |
| Market Cap | $1.84B | $2.02B | · | $2.39B | $2.46B | $2.39B | · | $3.00B | $2.56B | $3.89B | · | $3.00B | $2.91B | $2.95B | · | $2.49B | |
| Enterprise Value | $20.76B | $21.48B | · | $22.12B | $22.47B | $22.77B | · | $23.79B | $23.62B | $25.23B | · | $24.67B | $22.89B | $23.08B | · | $23.22B | |
| P/E | -1.7 | -1.7 | · | 6.7 | 26.6 | -53.9 | · | -17.0 | -5.4 | -8.6 | · | -3.1 | -15.7 | -8.3 | · | 9.6 | |
| P/S | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.4 | · | 0.4 | 0.3 | 0.4 | · | 0.3 | |
| P/B | -1.0 | -1.0 | · | -4.2 | -3.2 | -2.0 | · | -2.6 | -2.2 | -3.5 | · | -2.5 | -4.4 | -3.7 | · | -4.7 | |
| P / Cash Flow | · | 8.8 | · | · | · | 11.3 | · | · | · | 18.4 | · | · | · | 19.1 | · | · | |
| EV / Revenue | 1.9 | 2.0 | · | 2.2 | 2.3 | 2.3 | · | 2.5 | 2.6 | 2.8 | · | 2.9 | 2.7 | 2.8 | · | 2.9 | |
| Earnings Yield | -60.0% | -60.0% | · | 14.9% | 3.8% | -1.8% | · | -5.9% | -18.4% | -11.7% | · | -32.1% | -6.4% | -12.1% | · | 10.4% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $10.27B | $9.62B | $8.76B | $8.12B | $8.43B |
| Operating Margin % | 17.7% | 16.1% | 11.0% | 5.6% | 5.3% |
| Net Income | $157M | $-46M | $-592M | $-225M | $-948M |
| Diluted EPS | $0.42 | $-0.13 | $-1.62 | $-0.62 | $-2.64 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debt / Equity | -37.6 | -16.9 | -21.9 | -30.0 | -213.7 |
| Current Ratio | 1.5 | 0.9 | 1.3 | 1.1 | 1.1 |
| Quick Ratio | 0.9 | 0.5 | 0.7 | 0.6 | 0.5 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $1.00B | $1.26B | $817M | $-946M | $1.16B |
Institutional owners (13F) 263 filers · $1.3B total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
263
Value held
$1.3B
New positions
28
Exited positions
30
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 28 (-5 vs prior Q) | 30 (0 vs prior Q) | 78 (-11 vs prior Q) | 72 (+6 vs prior Q) | +11.6M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| PAULSON & CO. INC. | $361,151,434 | 73,255,869 | 28.47% | Shares |
| GOLDENTREE ASSET MANAGEMENT LP | $170,706,865 | 34,665,731 | 13.46% | Shares |
| VANGUARD GROUP INC | $74,149,574 | 10,679,760 | 5.85% | Shares |
| ROYAL BANK OF CANADA | $53,404,000 | 10,832,582 | 4.21% | Shares |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $39,440,000 | 8,000,000 | 3.11% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $36,797,292 | 7,465,468 | 2.90% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $33,169,671 | 4,803,485 | 2.61% | Shares |
| GOLDMAN SACHS GROUP INC | $30,689,896 | 6,225,131 | 2.42% | Shares |
| MFN Partners Management, LP | $29,580,000 | 6,000,000 | 2.33% | Shares |
| Kohlberg Kravis Roberts & Co. L.P. | $25,808,550 | 5,235,000 | 2.03% | Shares |
| ING GROEP NV | $24,650,000 | 5,000,000 | 1.94% | Shares |
| Hudson Bay Capital Management LP | $24,650,000 | 5,000,000 | 1.94% | Shares |
| GENDELL JEFFREY L | $19,902,859 | 4,037,091 | 1.57% | Shares |
| Lombard Odier Asset Management (USA) Corp | $19,720,000 | 4,000,000 | 1.55% | Put option |
| NORGES BANK | $16,914,543 | 3,431,117 | 1.33% | Shares |
| MACQUARIE GROUP LTD | $16,022,500 | 3,250,000 | 1.26% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $15,976,544 | 3,241,140 | 1.26% | Shares |
| D. E. Shaw & Co., Inc. | $13,258,130 | 2,689,942 | 1.05% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $11,094,735 | 2,250,910 | 0.87% | Shares |
| Point72 Asset Management, L.P. | $11,021,637 | 2,235,821 | 0.87% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $10,771,345 | 2,186,244 | 0.85% | Shares |
| TWO SIGMA INVESTMENTS, LP | $10,528,419 | 2,135,582 | 0.83% | Shares |
| PRIVATE MANAGEMENT GROUP INC | $8,301,316 | 1,683,837 | 0.65% | Shares |
| Qube Research & Technologies Ltd | $8,291,856 | 1,681,918 | 0.65% | Shares |
| BARCLAYS PLC | $8,134,500 | 1,650,000 | 0.64% | Put option |
| TWO SIGMA ADVISERS, LP | $7,366,576 | 1,059,939 | 0.58% | Shares |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $7,365,406 | 1,494,205 | 0.58% | Shares |
| Man Group plc | $7,157,280 | 1,451,781 | 0.56% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6,903,479 | 1,400,300 | 0.54% | Put option |
| RENAISSANCE TECHNOLOGIES LLC | $6,530,027 | 1,324,549 | 0.51% | Shares |
| MORGAN STANLEY | $6,174,733 | 1,252,481 | 0.49% | Shares |
| CITADEL ADVISORS LLC | $5,447,922 | 1,105,055 | 0.43% | Shares |
| MILLENNIUM MANAGEMENT LLC | $5,394,096 | 1,095,104 | 0.43% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5,138,046 | 1,042,200 | 0.41% | Call option |
| DEUTSCHE BANK AG\ | $4,930,000 | 1,000,000 | 0.39% | Call option |
| BANK OF MONTREAL /CAN/ | $4,856,469 | 986,351 | 0.38% | Shares |
| TD Asset Management Inc | $4,624,904 | 938,710 | 0.36% | Shares |
| SIG North Trading, ULC | $4,360,585 | 884,500 | 0.34% | Call option |
| JPMORGAN CHASE & CO | $4,272,070 | 880,839 | 0.34% | Shares |
| Bridgewater Associates, LP | $4,270,785 | 866,285 | 0.34% | Shares |
| Vanguard Global Advisers, LLC | $4,217,745 | 855,700 | 0.33% | Shares |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $3,712,320 | 753,006 | 0.29% | Shares |
| UBS Group AG | $3,668,940 | 744,207 | 0.29% | Shares |
| CITADEL ADVISORS LLC | $3,660,525 | 742,500 | 0.29% | Put option |
| GAMCO INVESTORS, INC. ET AL | $3,486,772 | 707,256 | 0.27% | Shares |
| WHITEBOX ADVISORS LLC | $3,030,333 | 614,672 | 0.24% | Shares |
| Jump Financial, LLC | $3,012,723 | 611,100 | 0.24% | Shares |
| TORONTO DOMINION BANK | $2,916,546 | 592,351 | 0.23% | Shares |
| BANK OF AMERICA CORP /DE/ | $2,815,928 | 571,182 | 0.22% | Shares |
| WOLVERINE ASSET MANAGEMENT LLC | $2,680,441 | 543,700 | 0.21% | Put option |
Activists & 5%+ owners 28 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Icahn Partners Master Fund LP, Icahn Offshore LP, Icahn Partners LP, Icahn Onshore LP, Icahn Capital LP, IPH GP LLC, Icahn Enterprises Holdings L.P., Icahn Enterprises G.P. Inc., Beckton Corp., Carl C. Icahn ×6 filings | Aug. 15, 2025 | 0.00% | Amendment | · | SEC |
| PAULSON & CO. INC. ×6 filings | Aug. 14, 2025 | 19.10% | Amendment | · | SEC |
| Alex Meruelo | April 7, 2025 | 9.99% | Initial filing | Passive investment | SEC |
| Aug. 19, 2024 | · | Initial filing | · | SEC | |
| Undisclosed reporting person, Undisclosed reporting person | May 13, 2022 | · | Initial filing | · | SEC |
| Glenview Capital Management, LLC, Larry Robbins ×2 filings | Dec. 13, 2021 | · | Initial filing | · | SEC |
| Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person | June 21, 2021 | · | Initial filing | Board campaign | SEC |
| Feb. 24, 2021 | · | Initial filing | · | SEC | |
| Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person | March 16, 2017 | · | Initial filing | Passive investment | SEC |
| Pershing Square Capital Management, L.P., PS Management GP, LLC, William A. Ackman ×12 filings | March 14, 2017 | · | Initial filing | · | SEC |
| Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person | June 15, 2015 | · | Initial filing | · | SEC |
| Valeant Pharmaceuticals International, Inc., Valeant Pharmaceuticals International ×10 filings | Nov. 20, 2014 | · | Initial filing | · | SEC |
| Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person | Sept. 25, 2014 | · | Initial filing | Passive investment | SEC |
| Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person | May 8, 2014 | · | Initial filing | Board campaign | SEC |
| Undisclosed reporting person, Undisclosed reporting person | May 23, 2012 | · | Initial filing | Passive investment | SEC |
| Undisclosed reporting person, Undisclosed reporting person | May 23, 2011 | · | Initial filing | · | SEC |
| Undisclosed reporting person, Undisclosed reporting person | May 11, 2011 | · | Initial filing | · | SEC |
| Undisclosed reporting person, Undisclosed reporting person | March 1, 2011 | · | Initial filing | · | SEC |
| Undisclosed reporting person, Undisclosed reporting person | Oct. 6, 2010 | · | Initial filing | M&A / sale | SEC |
| Undisclosed reporting person | June 29, 2010 | · | Initial filing | M&A / sale | SEC |
| Eugene Melnyk ×3 filings | March 22, 2010 | · | Initial filing | · | SEC |
| Undisclosed reporting person | Jan. 23, 2004 | · | Initial filing | · | SEC |
| Undisclosed reporting person | Nov. 10, 2003 | · | Initial filing | · | SEC |
| Undisclosed reporting person | Aug. 19, 2003 | · | Initial filing | · | SEC |
| Undisclosed reporting person | Dec. 12, 2002 | · | Initial filing | · | SEC |
| Undisclosed reporting person | May 8, 2002 | · | Initial filing | · | SEC |
| Undisclosed reporting person | Jan. 15, 2002 | · | Initial filing | · | SEC |
| Undisclosed reporting person | Sept. 28, 2001 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 79 insiders · 37 officers · 41 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Thomas Appio | Chief Executive Officer | March 2, 2026 J | 2,315,374 | 0 | 0 | $0 |
| Howard Bradley Schiller | Chairman and CEO | Feb. 18, 2016 F | 336,784 | 0 | 0 | $0 |
| Michael J. Pearson | Chief Executive Officer | Dec. 31, 2015 F | 1,514,664 | 0 | 0 | $0 |
| Jean-Jacques Charhon | EVP, CFO | Feb. 27, 2026 F | 706,478 | 0 | 0 | $0 |
| Tom George Vadaketh | EVP, Chief Financial Officer | Sept. 5, 2023 F | 564,933 | 0 | 0 | $0 |
| Sam Eldessouky | EVP & Chief Financial Officer | March 3, 2022 F | 119,455 | 0 | 0 | $0 |
| Philip Walden Loberg Jr | EVP, Interim CFO | July 25, 2011 A | 145,065 | 0 | 0 | $0 |
| Margaret Jean Mulligan | EVP, CFO | Nov. 11, 2010 A | 83,014 | 0 | 0 | $0 |
| Aimee J. Lenar | President, US Pharma | Aug. 19, 2026 S | 334,853 | 0 | 1 | $-258,894 |
| Robert Spurr | President, U.S. Businesses | May 10, 2022 M | 112,741 | 0 | 0 | $0 |
| William D. Humphries | President, Ortho-Dermatologics | Dec. 4, 2020 M | 235,035 | 0 | 0 | $0 |
| Mark C. Mckenna | President, Salix | Aug. 19, 2019 S | 20,756 | 0 | 0 | $0 |
| Rajiv De Silva | President and COO | Jan. 5, 2013 F | 259,767 | 0 | 0 | $0 |
| Richard Kevin Masterson | Pres. & COO, Valeant Intl. BB | May 10, 2012 S | 89,524 | 0 | 0 | $0 |
| Michel Chouinard | COO, Biovail Labs. Intl SRL | Dec. 22, 2010 A | 2,470 | 0 | 0 | $0 |
| Gilbert Godin | EVP & COO | July 5, 2010 A | · | 0 | 0 | $0 |
| Steven Hyosig Lee | SVP, Controller & CAO | July 14, 2026 F | 70,114 | 0 | 0 | $0 |
| Seana Carson | EVP, General Counsel | March 3, 2026 S | 616,761 | 0 | 3 | $-115,040 |
| John S Barresi | SVP, Controller & CAO | Feb. 28, 2025 F | 192,268 | 0 | 0 | $0 |
| Frederick Munsch | SVP, Controller and CAO | May 3, 2022 F | 22,435 | 0 | 0 | $0 |
| Christina Ackermann | EVP AND GENERAL COUNSEL | March 10, 2022 F | 162,240 | 0 | 0 | $0 |
| Joseph F Gordon | Pres&Co-Head Bausch&Lomb/Int'l | March 8, 2022 S | 93,139 | 0 | 0 | $0 |
| Robert L. Rosiello | EVP, Corp Dev & Strategy | Dec. 5, 2016 F | 517,683 | 0 | 0 | $0 |
| Ari Kellen | EVP, Company Group Chairman | Dec. 5, 2016 F | 630,842 | 0 | 0 | $0 |
| Anne Clem Whitaker | EVP, Company Group Chairman | Dec. 5, 2016 F | 158,544 | 0 | 0 | $0 |
| Robert Roswell Chai-Onn | EVP, CLO, General Counsel | May 12, 2016 A | 124,815 | 0 | 0 | $0 |
| Debora Jorn | EVP, Company Group Chairman | Nov. 20, 2015 F | 34,812 | 0 | 0 | $0 |
| Pavel Mirovsky | EVP, Pres. & GM Valeant EMENA | June 23, 2015 A | 69,525 | 0 | 0 | $0 |
| Brian M. Stolz | EVP, Administration & CHCO | June 22, 2015 F | 125,280 | 0 | 0 | $0 |
| Laizer Kornwasser | EVP, Company Group Chairman | April 27, 2015 D | 98,824 | 0 | 0 | $0 |
| Daniel Mark Wechsler | EVO, Co. Grp. Chmn, Eye Health | Aug. 12, 2013 A | · | 0 | 0 | $0 |
| Susan Hall | Global Head of R&D | July 26, 2013 M | 27,588 | 0 | 0 | $0 |
| Jason David Hanson | EVP, Company Group Chairman | Dec. 11, 2012 A | · | 0 | 0 | $0 |
| Mark Andrew Durham | SVP Human Resources | May 11, 2011 M | 61,595 | 0 | 0 | $0 |
| Christine Mayer | SVP, BTA Pharmaceuticals, Inc. | Oct. 4, 2010 A | 0 | 0 | 0 | $0 |
| Hans Christian Fibiger | Chief Scientific Officer | Oct. 4, 2010 A | 0 | 0 | 0 | $0 |
| Gregory David Gubitz | SVP, Corp. Devel. & GC | July 5, 2010 A | · | 0 | 0 | $0 |
| Amy B Wechsler | Director | Sept. 30, 2026 A | 316,158 | 0 | 0 | $0 |
| John Paulson | Director | Sept. 30, 2026 A | 440,962 | 0 | 0 | $0 |
| Sandra Leung | Director | Sept. 30, 2026 A | 102,859 | 0 | 0 | $0 |
| Frank D. Lee | Director | May 22, 2026 A | 95,210 | 0 | 1 | $-132,796 |
| Michael Goettler | Director | May 22, 2026 A | 76,020 | 0 | 0 | $0 |
| Eiry Roberts | Director | May 22, 2026 A | 45,871 | 0 | 0 | $0 |
| Sarah B Kavanagh | Director | May 22, 2026 A | 282,230 | 0 | 0 | $0 |
| Christian A Garcia | Director | May 22, 2026 A | 135,578 | 0 | 0 | $0 |
| Robert N Power | Director | May 22, 2026 A | 300,594 | 0 | 0 | $0 |
| Brett Icahn | Director | June 30, 2025 A | 220,280 | 0 | 0 | $0 |
| Steven D Miller | Director | May 16, 2025 A | 229,224 | 0 | 0 | $0 |
| Richard Mulligan | Director | May 16, 2025 A | 155,616 | 0 | 0 | $0 |
| Russel C Robertson | Director | March 29, 2024 A | 225,279 | 0 | 0 | $0 |
| Thomas W. Ross Sr. | Director | May 19, 2023 A | 161,516 | 0 | 0 | $0 |
| Richard U De Schutter | Director | March 31, 2023 A | 373,407 | 0 | 0 | $0 |
| Argeris N Karabelas | Director | June 24, 2022 A | 123,715 | 0 | 0 | $0 |
| Joseph C Papa | Director | May 10, 2022 M | 1,427,568 | 0 | 0 | $0 |
| Fredric N Eshelman | Director | May 5, 2017 A | 38,298 | 0 | 0 | $0 |
| Robert Alexander Ingram | Director | March 31, 2017 A | 92,046 | 0 | 0 | $0 |
| Ronald Harold Farmer | Director | May 2, 2016 A | 38,447 | 0 | 0 | $0 |
| Norma Ann Provencio | Director | May 2, 2016 A | 144,899 | 0 | 0 | $0 |
| Kyriazi Theo Melas | Director | May 2, 2016 A | 223,087 | 0 | 0 | $0 |
| Anders Lonner | Director | May 26, 2015 F | 29,891 | 0 | 0 | $0 |
| Katharine Berghuis Stevenson | Director | May 22, 2015 A | 24,705 | 0 | 0 | $0 |
| Colleen A Goggins | Director | May 22, 2015 A | 4,973 | 0 | 0 | $0 |
| Fred Hassan | Director | Aug. 29, 2013 P | 53,969 | 0 | 0 | $0 |
| Lloyd Mitchell Segal | Director | June 14, 2013 P | 21,174 | 0 | 0 | $0 |
| Mason G Morfit | Director | June 4, 2012 A | 81,106 | 0 | 0 | $0 |
| Laurence E Paul | Director | June 1, 2012 P | 60,459 | 0 | 0 | $0 |
| Michael Robert Van Every | Director | May 19, 2011 A | 6,397 | 0 | 0 | $0 |
| William Mcdowall Wells | Director | Dec. 7, 2010 M | 75,000 | 0 | 0 | $0 |
| Louis Randall Tull | Director | July 5, 2010 A | · | 0 | 0 | $0 |
| Douglas John Paul Squires | Director | July 5, 2010 A | 29,688 | 0 | 0 | $0 |
| John Spencer Lanthier | Director | July 5, 2010 A | · | 0 | 0 | $0 |
| Frank Potter | Director | July 5, 2010 A | · | 0 | 0 | $0 |
| David H. Laidley | Director | July 5, 2010 A | · | 0 | 0 | $0 |
| Mark W Parrish | Director | July 5, 2010 A | · | 0 | 0 | $0 |
| GOUIN SERGE | Director | July 5, 2010 A | · | 0 | 0 | $0 |
| PAULSON & CO. INC. | 10% owner | Nov. 25, 2025 P | 73,255,869 | 1 | 0 | $15,625,000 |
| Andrew C. Von Eschenbach | · | Aug. 5, 2021 P | 38,647 | 0 | 0 | $0 |
| Paul Herendeen | · | March 8, 2021 M | 386,618 | 0 | 0 | $0 |
| Ryan Weldon | · | April 28, 2014 M | 103,409 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 18 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| TLTD · FlexShares Trust | 0.08% | 78,045 NS | July 31, 2026 | N-PORT |
| ISCF · iShares Trust | 0.07% | 79,984 SH | Sept. 11, 2026 | Daily |
| DFIS · Dimensional ETF Trust | 0.04% | 336,568 NS | July 31, 2026 | N-PORT |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.03% | 978,582 SH | Aug. 19, 2026 | Daily |
| DISV · Dimensional ETF Trust | 0.03% | 214,485 NS | July 31, 2026 | N-PORT |
| DXIV · Dimensional ETF Trust | 0.03% | 7,943 NS | July 31, 2026 | N-PORT |
| PXF · Invesco Exchange-Traded Fund Trust … | 0.02% | 120,464 SH | Oct. 1, 2026 | Daily |
| WSML · iShares Trust | 0.02% | 16,543 SH | Sept. 10, 2026 | Daily |
| DFSI · Dimensional ETF Trust | 0.01% | 23,138 NS | July 31, 2026 | N-PORT |
| DFIC · Dimensional ETF Trust | 0.01% | 234,253 NS | July 31, 2026 | N-PORT |
| DFAX · Dimensional ETF Trust | 0.01% | 120,510 NS | July 31, 2026 | N-PORT |
| IDEV · iShares Trust | 0.01% | 364,677 SH | Sept. 11, 2026 | Daily |
| IXUS · iShares Trust | 0.00% | 379,290 SH | Sept. 11, 2026 | Daily |
| DFAI · Dimensional ETF Trust | 0.00% | 88,488 NS | July 31, 2026 | N-PORT |
| VXUS · VANGUARD STAR FUNDS | 0.00% | 3,762,192 SH | Aug. 19, 2026 | Daily |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.00% | 190,882 SH | Aug. 19, 2026 | Daily |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0.00% | 2,481,313 SH | Aug. 19, 2026 | Daily |
| VSGX · VANGUARD WORLD FUND | 0.00% | 52,499 SH | Aug. 19, 2026 | Daily |
BHC Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 8 analysts
SELL
Median target
$7.00
+20.7%
0 0.0%
Strong Buy
0 0.0%
Buy
4 50.0%
Hold
3 37.5%
Sell
1 12.5%
Strong Sell
12-Month Price Target
5 analysts · 2026-10-03Mean target $7.50 +29.3%
← Below all targets
Current price $5.80
Low$6.50
Mean$7.50
High$9.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| BHC | $2.58B | 16.5 | 6.7% | 1.5% | -17.1% | · |
| TLRY | $726M | -5.1 | 11.5% | -13.3% | -7.8% | 28.4% |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Jul 30, 2026